Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
N/A
The NAFLD is the first cause of liver disease worldwide. The severe form of...
Status
Completed
Location
Chu Amiens Picardie
Start Date
2021-02-16
Trial ID
NCT04616664
Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements
N/A
The purpose of this study is to compare the severity of NAFLD in diabetic p...
Status
Completed
Location
Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China